Work of Digital Vasoconstriction Produced by Infused Norepinephrine in Cushing's Syndrome

¹ From the Department of Medicine and the Andre Meyer Department of Physics, The Mount Sinai Hospital, the Research Service, First Division, Goldwater Memorial Hospital and the Department of Medicine, College of Physicians and Surgeons, Columbia University, New York City

Measurements of sensitivity of the digital blood vessels to infused norepinephrine were made in 4 patients with Cushing's syndrome due to adrenal cortical tumor or hyperplasia and 13 patients treated with ACS or ACTH. These were compared with similar measurements made in 15 untreated normotensive subjects. Norepinephrine sensitivity was increased in Cushing's syndrome and in patients treated with ACS and ACTH despite the absence of significant hypertension in the latter group. The evidence suggests that ACTH indirectly and ACS directly may inhibit those chemical substances present in the walls of blood vessels which are responsible for inactivating norepinephrine.

This article has been cited by other articles:

				S. Murasawa, H. Matsubara, K. Kizima, K. Maruyama, Y. Mori, and M. Inada Glucocorticoids Regulate V1a Vasopressin Receptor Expression by Increasing mRNA Stability in Vascular Smooth Muscle Cells Hypertension, October 1, 1995; 26(4): 665 - 669. [Abstract] [Full Text]